McWherter C A, Feng Y, Zurfluh L L, Klein B K, Baganoff M P, Polazzi J O, Hood W F, Paik K, Abegg A L, Grabbe E S, Shieh J J, Donnelly A M, McKearn J P
Searle Discovery Research, Monsanto Company, St. Louis, Missouri 63198, USA.
Biochemistry. 1999 Apr 6;38(14):4564-71. doi: 10.1021/bi982225g.
Myelopoietins (MPOs) are a family of engineered dual interleukin-3 (IL-3) and granulocyte colony-stimulating factor (G-CSF) receptor agonists that are superior in comparison to the single agonists in their ability to promote the growth and maturation of hematopoietic cells of the myeloid lineage. A series of MPO molecules were created which incorporated circularly permuted G-CSF (cpG-CSF) sequences with an IL-3 receptor (IL-3R) agonist moiety attached at locations that correspond to the loops that connect the helices of the G-CSF four-helix bundle structure. The cpG-CSF linkage sites (using the original sequence numbering) were residue 39, which is at the beginning of the first loop connecting helices 1 and 2; residue 97, which is in the turn connecting helices 2 and 3; and residues 126, 133, and 142, which are at the beginning, middle, and end, respectively, of the loop connecting helices 3 and 4. The N- and C-terminal helices of each cpG-CSF domain were constrained, either by direct linkage of the termini (L0) or by replacement of the amino-terminal 10-residue segment with a seven-residue linker composed of SGGSGGS (L1). All of the MPO molecules stimulated the proliferation of both IL-3-dependent (EC50 = 13-95 pM) and G-CSF-dependent (EC50 = 35-710 pM) cell lines. MPOs with the IL-3R agonist domain linked to cpG-CSFs in the first (residue 39) or second (residue 133) long overhand loops were found by CD spectroscopy to have helical contents similar to that expected for a protein comprised of two linked four-helix bundles. The MPOs retained the ability to bind to the IL-3R with affinities similar to that of the parental MPO. Using both a cell surface competitive binding assay and surface plasmon resonance detection of binding kinetics, the MPOs were found to bind to the G-CSF receptor with low nanomolar affinities, similar to that of G-CSF(S17). In a study of isolated cpG-CSF domains [Feng, Y., et al. (1999) Biochemistry 38, 4553-4563], domains with the L1 linker had lower G-CSF receptor-mediated proliferative activities and conformational stabilities than those which had the L0 linker. A similar trend was found for the MPOs in which the G-CSFR agonist activity is mostly a property of the cpG-CSF domain. Important exceptions were found in which the linkage to the IL-3R agonist domain either restored (e.g., attachment at residue 142) or further decreased (linkage at residue 39) the G-CSFR-mediated proliferative activity. MPO in which the IL-3R agonist domain is attached to the cpG-CSF(L1)[133/132] domain was shown to be more potent than the coaddition of the IL-3R agonist and G-CSF in stimulating the production of CFU-GM colonies in a human bone marrow-derived CD34+ colony-forming unit assay. Several MPOs also had decreased proinflammatory activity in a leukotriene C4 release assay using N-formyl-Met-Leu-Phe-primed human monocytes. It was found that circular permutation of the G-CSF domain can alter the ratio of G-CSFR:IL-3R agonist activities, demonstrating that it is a useful tool in engineering chimeric proteins with therapeutic potential.
髓系生成素(MPOs)是一类经过改造的双功能白细胞介素-3(IL-3)和粒细胞集落刺激因子(G-CSF)受体激动剂,与单一激动剂相比,它们在促进髓系造血细胞生长和成熟方面表现更优。人们构建了一系列MPO分子,这些分子包含环状排列的G-CSF(cpG-CSF)序列,并在与G-CSF四螺旋束结构中连接螺旋的环相对应的位置连接了一个IL-3受体(IL-3R)激动剂部分。cpG-CSF的连接位点(使用原始序列编号)分别为:第39位残基,位于连接螺旋1和2的第一个环的起始处;第97位残基,位于连接螺旋2和3的转角处;以及第126、133和142位残基,分别位于连接螺旋3和4的环的起始、中间和末端。每个cpG-CSF结构域的N端和C端螺旋通过末端直接连接(L0)或用由SGGSGGS组成的七肽接头替换氨基末端的10个残基片段(L1)进行限制。所有的MPO分子都能刺激IL-3依赖型(EC50 = 13 - 95 pM)和G-CSF依赖型(EC50 = 35 - 710 pM)细胞系的增殖。通过圆二色光谱法发现,IL-3R激动剂结构域连接到cpG-CSF的第一个(第39位残基)或第二个(第133位残基)长环上的MPO分子,其螺旋含量与由两个相连的四螺旋束组成的蛋白质预期的螺旋含量相似。MPO分子保留了与IL-3R结合的能力,其亲和力与亲本MPO相似。通过细胞表面竞争性结合试验和表面等离子体共振检测结合动力学发现,MPO分子以低纳摩尔亲和力与G-CSF受体结合,与G-CSF(S17)相似。在对分离的cpG-CSF结构域的研究中[Feng, Y.,等人(1999年)《生物化学》38, 4553 - 4563],具有L1接头的结构域比具有L0接头的结构域具有更低的G-CSF受体介导的增殖活性和构象稳定性。对于MPO分子也发现了类似的趋势,其中G-CSFR激动剂活性主要是cpG-CSF结构域的特性。但也发现了重要的例外情况,即与IL-3R激动剂结构域的连接要么恢复了(例如,连接在第142位残基处),要么进一步降低了(连接在第39位残基处)G-CSFR介导的增殖活性。在人骨髓来源的CD34 +集落形成单位试验中,IL-3R激动剂结构域连接到cpG-CSF(L1)[133/132]结构域的MPO在刺激CFU-GM集落产生方面比同时添加IL-3R激动剂和G-CSF更有效。在使用N-甲酰基-Met-Leu-Phe预处理的人单核细胞的白三烯C4释放试验中,几种MPO的促炎活性也有所降低。发现G-CSF结构域的环状排列可以改变G-CSFR:IL-3R激动剂活性的比例,表明它是构建具有治疗潜力的嵌合蛋白的有用工具。